Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2011-06-10FDA Approved: JANUMET — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for JANUMET (sitagliptin/metformin hydrochloride) submitted by Merck Sharp & Dohme LLC, updating the…
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: Acetylcarnitine and Insulin Sensitivity [Phase 2]
A Phase 2 clinical trial evaluated acetylcarnitine for improving insulin sensitivity in Type 2 Diabetes Mellitus. The study status is comple…
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: A Multiple-Ascending Dose Study in Type 2 Diabetes Mellitus Patients [Phase 1]
This document reports a completed Phase 1 multiple-ascending dose trial in patients with Type 2 diabetes mellitus, conducted by Eli Lilly.
-
CLINICAL_TRIALS trial_result · 2011-06-09Clinical Trial Update: The Effect of Hyperglycemia on LV Function and Exercise Capacity in Diabetics With and Without Heart Failure. [Phase 2]
Phase 2 clinical trial evaluating how hyperglycemia affects left ventricular function and exercise capacity in people with Type 2 diabetes, …
-
CLINICAL_TRIALS trial_result · 2011-06-09Clinical Trial Update: Evaluating the Efficacy and Safety of Dehypotin® in the Patients With Type 2 Diabetes Mellitus or Cardiovascular Disease [Phase 4]
A Phase 4 clinical trial evaluating Dehypotin in patients with Type 2 Diabetes Mellitus and cardiovascular disease was TERMINATED, with hype…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Study of the Safety and Effectiveness of Topiramate on Insulin Sensitivity in Overweight or Obese Patients With Type 2 Diabetes [Phase 2]
A Phase 2 study evaluated the safety and potential improvement in insulin sensitivity with Topiramate in overweight or obese adults with Typ…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Study To Evaluate The Effect Of Topiramate On Clinical And Electrophysiological Parameters In Subjects With Diabetic Peripheral Polyneuropathy [Phase 2]
A Phase 2 trial evaluating the effect of topiramate on clinical and electrophysiological parameters in subjects with diabetic peripheral pol…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Study of the Safety and Efficacy of Topiramate in the Treatment of Obese, Type 2 Diabetes Patients on a Controlled Diet [Phase 3]
Phase 3 trial evaluating topiramate for weight loss and glycemic management in obese adults with type 2 diabetes on a controlled diet. The s…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Study of the Efficacy and Safety of Topiramate in the Treatment fo Obese, Type 2 Diabetic Patients Treated With Metformin [Phase 3]
A Phase 3 trial assessing the efficacy and safety of topiramate added to metformin in obese adults with Type 2 Diabetes Mellitus has complet…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: Insulin Glargine During and After the Period of Fasting in Ramadan [Phase 4]
A Phase 4 trial assessed insulin glargine use during and after Ramadan fasting in people with Type 2 diabetes, and the study has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Study on Efficacy and Safety of Topiramate OROS Controlled-Release in Obese, Type 2 Diabetic Subjects Managed With Diet or Metformin [Phase 2]
Phase 2 study evaluating the efficacy and safety of Topiramate OROS Controlled-Release in obese adults with Type 2 diabetes mellitus managed…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: Does Bone Structure Explain the Increased Fracture Risk in Type II Diabetes Patients? A Pilot Study
A completed pilot trial investigates whether bone structure explains the higher fracture risk in patients with type 2 diabetes, focusing on …
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Study of the Efficacy and Safety of Topiramate in Obese, Type 2 Diabetic Patients Inadequately Controlled on Sulfonylurea Therapy [Phase 3]
Phase 3 trial evaluating topiramate for obesity in adults with type 2 diabetes inadequately controlled on sulfonylurea therapy; the study ha…
-
CLINICAL_TRIALS trial_result · 2011-06-07Clinical Trial Update: Efficacy and Safety of BI 1356 (Linagliptin) Versus Placebo in Type 2 Diabetic Patients With Insufficient Glycemic Control [Phase 3]
A Phase 3 trial comparing BI 1356 (linagliptin) to placebo in adults with type 2 diabetes and inadequate glycemic control has completed, wit…
-
CLINICAL_TRIALS trial_result · 2011-06-07Clinical Trial Update: Efficacy and Safety of 3 Doses of BI1356 (Linagliptin) in Type 2 Diabetes Patients [Phase 2]
This Phase 2 study evaluated the efficacy and safety of three doses of BI1356 (linagliptin) in patients with type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2011-06-07Clinical Trial Update: Telmisartan Fixed Dose Combination vs Amlodipine in Hypertensive Patients With Type 2 Diabetes Mellitus [Phase 3]
Phase 3 trial comparing telmisartan fixed-dose combination against amlodipine in hypertensive patients with type 2 diabetes mellitus complet…
-
CLINICAL_TRIALS trial_result · 2011-06-07Clinical Trial Update: Efficacy vs Placebo as Initial Combination Therapy With Pioglitazone [Phase 3]
A Phase 3 clinical trial compared initial combination therapy including pioglitazone to placebo in adults with type 2 diabetes mellitus, wit…
-
CLINICAL_TRIALS trial_result · 2011-06-07Clinical Trial Update: Efficacy and Safety of B I1356 (Linagliptin) vs. Placebo Added to Metformin Background Therapy in Patients With Type 2 Diabetes [Phase 3]
Phase 3 trial results compare linagliptin added to metformin versus placebo in adults with type 2 diabetes, assessing efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2011-06-07Clinical Trial Update: Effect of the Chromium Nicotinate on Type 2 Diabetes [Phase 3]
A Phase 3 clinical trial evaluating chromium nicotinate for Type 2 diabetes; the current status of the study is listed as UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2011-06-06Clinical Trial Update: A Study Of PF-03882845 Absorption In Healthy Volunteers Given Orally As Tablet Versus Suspension Formulations And Effect Of Food On Its Absorption [Phase 1]
This Phase 1 trial from Pfizer assessed the absorption of PF-03882845 in healthy volunteers when given as a tablet versus a suspension and t…
-
CLINICAL_TRIALS trial_result · 2011-06-06Clinical Trial Update: Adverse Events in Pharmaceutical Bioequivalence Study of Two Formulations of Metformine Hydrochloride 500 mg [NA]
Adverse events observed in a bioequivalence study comparing two formulations of metformin hydrochloride 500 mg are reported.
-
CLINICAL_TRIALS other · 2011-06-01Clinical Trial Update: Primary Prevention of Major Adverse Cardiac Events (MACE) With Standard and Intensive Statin Treatment in Patients With Diabetes: Survival and Cardiovascular Event Assessments [NA]
Clinical trial evaluating standard versus intensive statin therapy for primary prevention of major adverse cardiovascular events in patients…
-
FDA approval · 2011-05-31FDA Approved: GLYBURIDE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for glyburide from Heritage Pharmaceuticals (Avet) to an already-approved generic product (ANDA), in…
-
CLINICAL_TRIALS research · 2011-05-30Clinical Trial Update: Less Invasive Detection and Treatment of Very Early Coronary Artery Disease in Patients With Diabetes Mellitus [NA]
This clinical trial update discusses a less invasive approach to detecting and treating very early coronary artery disease in patients with …
-
FDA approval · 2011-05-25FDA Approved: ACARBOSE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for acarbose (ACARBOSE) from Hikma Pharmaceuticals USA Inc., updating an existing approval for t…